Skip to content

PCORI-CER-1306-03385 Informed Decisions About Lung Cancer Screening

Promoting Informed Decisions About Lung Cancer Screening: Randomized Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02286713
Enrollment
516
Registered
2014-11-10
Start date
2015-03-31
Completion date
2020-12-30
Last updated
2021-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer, Smoking Cessation, Tobacco Use Cessation

Keywords

Lung Cancer Screening, heavy smokers, state-based smoking cessation quitlines, patient decision aid, low-dose computed tomography, LDCT, standard educational information

Brief summary

Educational research study where goal is to test educational materials that help people make informed decisions about lung cancer screening.

Detailed description

This is the second phase of a larger project funded by the Patient-Centered Outcomes Research Institute to help heavy smokers make informed decisions about lung cancer screening with low-dose computed tomography (LDCT). The aim of this phase is to compare outcomes for promoting informed screening decisions about lung cancer screening in a randomized trial of patients who smoke recruited through state-based smoking cessation quitlines, where patients will be randomly assigned to the updated patient decision aid or to standard educational materials on lung cancer screening.

Interventions

BEHAVIORALFollow-Up Assessments: Questionnaires

Follow up questions administered via phone and/or mail at 1-week, 3-month, and 6-month

Participants will receive study materials including a video to watch about lung cancer screening

BEHAVIORALStandard Educational Information

Participants will receive study materials including a booklet to read about lung cancer screening.

Sponsors

Patient-Centered Outcomes Research Institute
CollaboratorOTHER
M.D. Anderson Cancer Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
55 Years to 77 Years
Healthy volunteers
Yes

Inclusion criteria

1. Men and women 55 to 77 years of age. 2. Participants must speak English. 3. Current smoker or quit smoking within the past 15 years. 4. At least a 30 pack-year smoking history.

Exclusion criteria

1\) History of lung cancer.

Design outcomes

Primary

MeasureTime frameDescription
Mean Value: Preparation for Decision Making© ScaleAssessment at 1-week follow-up.The Preparation for Decision Making© Scale assesses a patient's perception of how useful a decision aid or other decision support intervention is in preparing the respondent to communicate with their practitioner at a consultation visit and making a health decision. The scale is scored by summing the 10 items and dividing by 10. Scores are then converted to a 0-100 scale by subtracting 1 and multiplying by 25. Higher scores indicate higher perceived level of preparation for decision making. For this study, researchers used the patient version of the Preparation for Decision Making© scale, adapted for Lung Cancer Screening (LCS) context.
Mean Value: Informed Subscale of the Decisional Conflict Scale©Assessment at 1-week follow-up.A 3-item subscale that measures the degree to which the patient feels informed in making a decision about lung cancer screening. Total scores range from 0 (feels extremely informed) to 100 (feels extremely uninformed) related to making a decision. The scale was adapted for the LCS context.
Mean Value: Values Clarity Subscale of the Decisional Conflict Scale©Assessment at 1-week follow-up.A 3-item subscale that measures the degree to which the patient feels clear about his or her values related to the lung cancer screening decision, including values about the harms and benefits. Total scores range from 0 (feels extremely clear about personal value for benefits and risks/side effects of screening) 100 (feels extremely unclear about personal value for benefits and risks/side effects of screening) related to making a decision. The scale was adapted for the LCS context.

Secondary

MeasureTime frameDescription
Mean Value: Knowledge of Lung Cancer ScreeningOne week to 6 months, assessments at 1-week, 3-months and 6-months follow-up.A 12-item, self-report measure of the patient's knowledge of facts related to lung cancer and lung cancer screening, including the harms and benefits of testing. The knowledge scale yields a single score, representing the percentage of correct responses (ranging from 0% to 100% correct). Higher scores indicate greater knowledge.

Countries

United States

Participant flow

Recruitment details

Recruitment Period: March 2015 to September 2016 from tobacco quitline new and former callers.

Pre-assignment details

After consent participants completed baseline assessments prior to randomization.

Participants by arm

ArmCount
Patient Decision Aid
Decision Aid study materials including video mailed to participant with 1-week, 3-month, and 6-month follow-up assessments
259
Standard Educational Information
Study materials including education booklet mailed to participant with 1-week, 3-month, and 6-month follow-up assessments
257
Total516

Withdrawals & dropouts

PeriodReasonFG000FG001
One Week Follow-UpDeath10
One Week Follow-UpLost to Follow-up1721
One Week Follow-UpWithdrawal by Subject63
Six Month Follow-UpDeath20
Six Month Follow-UpLost to Follow-up3027
Three Month Follow-UpDeath11
Three Month Follow-UpLost to Follow-up2624
Three Month Follow-UpWithdrawal by Subject11

Baseline characteristics

CharacteristicPatient Decision AidStandard Educational InformationTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
69 Participants77 Participants146 Participants
Age, Categorical
Between 18 and 65 years
190 Participants180 Participants370 Participants
Age, Continuous61.5 years
STANDARD_DEVIATION 5
61.7 years
STANDARD_DEVIATION 5.8
61.6 years
STANDARD_DEVIATION 5.4
Participant Education Level
Graduated college or more
39 Participants39 Participants78 Participants
Participant Education Level
Graduated high school/GED
72 Participants77 Participants149 Participants
Participant Education Level
Less than High School
41 Participants36 Participants77 Participants
Participant Education Level
Some college/Trade school
107 Participants105 Participants212 Participants
Participant Health Insurance Status
Does not have insurance
20 Participants27 Participants47 Participants
Participant Health Insurance Status
Has insurance
239 Participants230 Participants469 Participants
Participant Pack-Year Smoking History47.0 pack-years49.0 pack-years48.0 pack-years
Race/Ethnicity, Customized
American Indian or Alaska Native
2 Participants0 Participants2 Participants
Race/Ethnicity, Customized
Asian
0 Participants0 Participants0 Participants
Race/Ethnicity, Customized
Black or African American
62 Participants76 Participants138 Participants
Race/Ethnicity, Customized
Hispanic or Latino
7 Participants1 Participants8 Participants
Race/Ethnicity, Customized
More than one race
1 Participants1 Participants2 Participants
Race/Ethnicity, Customized
Native Hawaiian or Other Pacific Islander
0 Participants1 Participants1 Participants
Race/Ethnicity, Customized
Other
2 Participants0 Participants2 Participants
Race/Ethnicity, Customized
Refused
0 Participants1 Participants1 Participants
Race/Ethnicity, Customized
White
185 Participants177 Participants362 Participants
Region of Enrollment
United States
259 participants257 participants516 participants
Sex: Female, Male
Female
157 Participants163 Participants320 Participants
Sex: Female, Male
Male
102 Participants94 Participants196 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
4 / 2591 / 257
other
Total, other adverse events
0 / 2590 / 257
serious
Total, serious adverse events
0 / 2590 / 257

Outcome results

Primary

Mean Value: Informed Subscale of the Decisional Conflict Scale©

A 3-item subscale that measures the degree to which the patient feels informed in making a decision about lung cancer screening. Total scores range from 0 (feels extremely informed) to 100 (feels extremely uninformed) related to making a decision. The scale was adapted for the LCS context.

Time frame: Assessment at 1-week follow-up.

Population: All participants providing data at the 1-week follow-up where one participant in the Decision Aid Arm did not answer the scale questions and was dropped from the analysis.

ArmMeasureValue (MEAN)Dispersion
Patient Decision AidMean Value: Informed Subscale of the Decisional Conflict Scale©27.1 units on a scaleStandard Deviation 25.9
Standard Educational InformationMean Value: Informed Subscale of the Decisional Conflict Scale©42.1 units on a scaleStandard Deviation 30.8
Primary

Mean Value: Preparation for Decision Making© Scale

The Preparation for Decision Making© Scale assesses a patient's perception of how useful a decision aid or other decision support intervention is in preparing the respondent to communicate with their practitioner at a consultation visit and making a health decision. The scale is scored by summing the 10 items and dividing by 10. Scores are then converted to a 0-100 scale by subtracting 1 and multiplying by 25. Higher scores indicate higher perceived level of preparation for decision making. For this study, researchers used the patient version of the Preparation for Decision Making© scale, adapted for Lung Cancer Screening (LCS) context.

Time frame: Assessment at 1-week follow-up.

Population: Of participants providing data at the 1-week follow-up, seventeen(17) of the participants did not answer the scale items and were therefore dropped from analysis.

ArmMeasureValue (MEAN)Dispersion
Patient Decision AidMean Value: Preparation for Decision Making© Scale79.4 units on a scaleStandard Deviation 17.7
Standard Educational InformationMean Value: Preparation for Decision Making© Scale69.4 units on a scaleStandard Deviation 22.7
Primary

Mean Value: Values Clarity Subscale of the Decisional Conflict Scale©

A 3-item subscale that measures the degree to which the patient feels clear about his or her values related to the lung cancer screening decision, including values about the harms and benefits. Total scores range from 0 (feels extremely clear about personal value for benefits and risks/side effects of screening) 100 (feels extremely unclear about personal value for benefits and risks/side effects of screening) related to making a decision. The scale was adapted for the LCS context.

Time frame: Assessment at 1-week follow-up.

Population: Of participants providing data at the 1-week follow-up, one participant in the Standard Educational Information group did not answer the Values Clarity Subscale questions and was dropped from the analysis and where one participant in the Decision Aid Arm did not answer the scale questions and was dropped from the analysis.

ArmMeasureValue (MEAN)Dispersion
Patient Decision AidMean Value: Values Clarity Subscale of the Decisional Conflict Scale©17.6 units on a scaleStandard Deviation 26.2
Standard Educational InformationMean Value: Values Clarity Subscale of the Decisional Conflict Scale©31.7 units on a scaleStandard Deviation 32.8
Secondary

Mean Value: Knowledge of Lung Cancer Screening

A 12-item, self-report measure of the patient's knowledge of facts related to lung cancer and lung cancer screening, including the harms and benefits of testing. The knowledge scale yields a single score, representing the percentage of correct responses (ranging from 0% to 100% correct). Higher scores indicate greater knowledge.

Time frame: One week to 6 months, assessments at 1-week, 3-months and 6-months follow-up.

Population: For the participants providing data at the 1-week follow-up, no data was missing in either group.

ArmMeasureGroupValue (MEAN)Dispersion
Patient Decision AidMean Value: Knowledge of Lung Cancer ScreeningOne-week57.5 percentage of correct responsesStandard Deviation 21.8
Patient Decision AidMean Value: Knowledge of Lung Cancer Screening6-Months49.9 percentage of correct responsesStandard Deviation 17.8
Patient Decision AidMean Value: Knowledge of Lung Cancer Screening3-Months44.4 percentage of correct responsesStandard Deviation 19.6
Standard Educational InformationMean Value: Knowledge of Lung Cancer ScreeningOne-week40.1 percentage of correct responsesStandard Deviation 17.1
Standard Educational InformationMean Value: Knowledge of Lung Cancer Screening3-Months35.9 percentage of correct responsesStandard Deviation 16.9
Standard Educational InformationMean Value: Knowledge of Lung Cancer Screening6-Months40.0 percentage of correct responsesStandard Deviation 18.1

Source: ClinicalTrials.gov · Data processed: Mar 6, 2026